C - Chemistry – Metallurgy – 07 – H
Patent
C - Chemistry, Metallurgy
07
H
C07H 21/00 (2006.01) A61K 31/7088 (2006.01) A61K 31/7105 (2006.01) A61K 31/7125 (2006.01) A61K 48/00 (2006.01) C07H 21/02 (2006.01) C12N 15/11 (2006.01) C12Q 1/68 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2453295
The invention relates to oligoribonucleotide derivatives that have, at the 3' end, a 2'5'-linked oligoribonucleotide radical without a 5' phosphate radical and to their use for the targeted inhibition of gene expression.
L'invention concerne des dérivés d'oligoribonucléotide présentant à une extrémité 3', un reste oligoribonucléotide lié en 2'5', sans reste 5'-phosphate, ainsi que leur utilisation pour l'inhibition orientée de l'expression génique.
Gunkel Niki
Huber Jochen
Neumann Sandra
Uhlmann Eugen
Aventis Pharma Deutschland Gmbh
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Sanofi-Aventis Deutschland Gmbh
LandOfFree
Novel oligoribonucleotide derivatives for specific... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel oligoribonucleotide derivatives for specific..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel oligoribonucleotide derivatives for specific... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1457200